Talk:Anakinra

Mechanism
The citation for this line "Anakinra differs from native human IL-1Ra in that it has the addition of a single methionine residue at its amino terminus" has a tooltip that is malformed, and I don't know how to fix it. — Preceding unsigned comment added by Regarr (talk • contribs) 21:48, 3 February 2016 (UTC)

kinneret x kineret
Hello... according to http://en.wikipedia.org/wiki/Kineret the drug has two n's. Can someone please double-check? In this article's intro sentence it has only one n. -- leuce (talk) 11:06, 13 March 2009 (UTC)


 * It has only one n. SteveD 7:31am 03-10-09 —Preceding unsigned comment added by 122.104.7.242 (talk) 21:31, 2 October 2009 (UTC)

Is it a DMARD
I'm not sure about the statement that it isn't a DMARD. From my readings it seems that there can be overlap between DMARDs and BRMs. The fact that it is a BRM distinguishes it from older non-specific medications like methotrexate, leflunomide, sulfasalazine, etc but it is still a DMARD because it is antirheumatic and slows the progression of the disease. I believe the American College of Rheumatology guidelines just calls it a biologic DMARD. 192.138.67.36 (talk)

pediatric use
Hey there! The article states that the pediatric use is contraindicated, but the prescribing information (http://www.kineretrx.com/fileadmin/user_upload/kineretus/documents/Kineret_Full_Prescribing_Information.pdf) states that it is indicated in NOMID (but not JRA) -> see section 8.4. I'm not sure how to add that information to the article.. Maybe a pharmacist here who can do that? mfg GierAffe — Preceding unsigned comment added by 62.2.176.4 (talk) 16:35, 9 May 2013 (UTC)

Is it still fda approved
I can't find any info if anakinra is still fda approved or not &#91;&#91;User:A915&#124;A915&#93;&#93; a (talk) 19:02, 10 March 2014 (UTC)

what and when approved
Article does not say when FDA/EU etc approved it and any subsequent approvals. Article reads like an advert and copy of the package insert. Needs more inline cites. - Rod57 (talk) 11:36, 27 September 2016 (UTC)

UK NICE would not recommend in 2003
[https://www.nice.org.uk/guidance/ta72/documents/final-appraisal-determination-anakinra-for-rheumatoid-arthritis2 Final Appraisal Determination - Anakinra for rheumatoid arthritis. 2003] says "... anakinra is not recommended for the treatment of rheumatoid arthritis, except in the context of a controlled, long-term clinical study. ". Should mention ? - Rod57 (talk) 12:15, 27 September 2016 (UTC)

Cost $4,000 a month
Nothing in this entry yet on cost. This Washington Post story mentions that private insurance companies pay an average of $4,000 a month, but that figure may vary widely. I would rather look it up in Medical Letter, a MEDMOS peer-reviewed source.

https://www.washingtonpost.com/wellness/2023/01/30/high-priced-drugs-step-insurance-policies/

I wrote about high-priced drugs for years. Then my toddler needed one.

As a health and science reporter, I’ve studied the maze of U.S. health care. But when my son got sick, I still got lost.

Perspective by Carolyn Y. Johnson

Washington Post

January 30, 2023

Nbauman (talk) 20:45, 31 January 2023 (UTC)

Citation style
Hi. I am a little confused by your like and revert. First established author style was in this edit. Note that subsequent to that edit, authors has been depreciated and replaced with vauthors. Also vauthors has been used consistently throughout this article. Boghog (talk) 19:19, 28 October 2023 (UTC)


 * @Boghog I didn't mean to revert and hadn't realised I had: the two links for "undo" and "thank" are dangerously near when editing on a small phone screen. It asks for confirmation before thanking, but apparently not for undoing. Poor design. It's a pity that the "vauthors" isn't what the automatic reference creator from doi generates, but of course I agree with consistent citation style. Sorry about that. Pam  D  20:05, 28 October 2023 (UTC)
 * I think it must have been "rollback", as "undo" opens an edit screen. Problems of mobile editing. Sorry. Pam  D  20:11, 28 October 2023 (UTC)


 * No worries. I have accidentally done the same thing while using mobile.  Cheers. Boghog (talk) 05:29, 29 October 2023 (UTC)

EU licensing
The EU licence field was recently removed from the infobox, and I have tried to replace it, by adding, after reading Infobox drug. But the link generated leads to a "page not found". The EU page exists at https://www.ema.europa.eu/en/medicines/human/EPAR/kineret. Why is the link not working, any ideas?

I almost never edit pharmaceutical articles, and medical articles only rarely, but I have a strong personal interest in this one (did my daily injection half an hour ago). Pam D  08:24, 15 March 2024 (UTC)